rs200450661
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_005379.4(MYO1A):c.1928G>A(p.Arg643Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,614,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_005379.4 missense
Scores
Clinical Significance
Conservation
Publications
- nonsyndromic genetic hearing lossInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYO1A | NM_005379.4 | c.1928G>A | p.Arg643Gln | missense_variant | Exon 18 of 28 | ENST00000300119.8 | NP_005370.1 | |
| MYO1A | NM_001256041.2 | c.1928G>A | p.Arg643Gln | missense_variant | Exon 19 of 29 | NP_001242970.1 | ||
| MYO1A | XM_047428876.1 | c.1928G>A | p.Arg643Gln | missense_variant | Exon 19 of 29 | XP_047284832.1 | ||
| MYO1A | XM_011538373.3 | c.1928G>A | p.Arg643Gln | missense_variant | Exon 18 of 25 | XP_011536675.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYO1A | ENST00000300119.8 | c.1928G>A | p.Arg643Gln | missense_variant | Exon 18 of 28 | 1 | NM_005379.4 | ENSP00000300119.3 | ||
| MYO1A | ENST00000442789.6 | c.1928G>A | p.Arg643Gln | missense_variant | Exon 19 of 29 | 1 | ENSP00000393392.2 | |||
| MYO1A | ENST00000554234.5 | n.1442G>A | non_coding_transcript_exon_variant | Exon 14 of 24 | 5 | ENSP00000451033.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152172Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000319 AC: 8AN: 250974 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1461862Hom.: 0 Cov.: 33 AF XY: 0.0000371 AC XY: 27AN XY: 727228 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152290Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74460 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:1
p.Arg643Gln in exon 18 of MYO1A: This variant is not expected to have clinical significance because the arginine (Arg) residue at position 643 is not conserved in mammals or across species, with guinea pig and rabbit having a glutamine (Gl n). In addition, recent evidence has disqualified an association between variant s in the MYO1A gene and hearing loss (Eisenberger 2014). This variant has also been identified in 0.5% (1/192) of Kenyan chromosomes by the 1000 Genomes Projec t (rs200450661). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at